By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Neurobiological Technologies, Inc. 

2000 Powell Street
Suite 800
Emeryville  California  94608  U.S.A.
Phone: 510-595-6000 Fax: 510-595-6006


SEARCH JOBS



Segment
Drug Discovery





Company News
Neurobiological Technologies, Inc. (NTII) Announces Dividend of $0.05 Per Share 12/17/2012 9:39:08 AM
Neurobiological Technologies, Inc. (NTII) Announces Extraordinary Dividend of $0.18 per Share Company also Announces Timing and Plans to Voluntarily Delist from the Nasdaq Capital Market and Initiate Dissolution Process 11/23/2009 9:52:26 AM
Neurobiological Technologies, Inc. (NTII) Announces Intent to File Form 25 to Delist Common Stock From the The Nasdaq Stock Market -- New York Capital Market 10/20/2009 11:24:20 AM
Neurobiological Technologies, Inc. (NTII) Board Approves Liquidation Plan 9/1/2009 7:56:58 AM
Neurobiological Technologies, Inc. (NTII) Announces Termination of its License and Cooperation Agreement with Merz Pharmaceuticals, LLC and Children's Medical Center 8/12/2009 6:43:47 AM
Celtic Pharma Announces Results of XERECEPT(R) Phase 3 Clinical Program 6/1/2009 11:30:58 AM
Neurobiological Technologies, Inc. (NTII) Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine 5/4/2009 7:54:45 AM
Neurobiological Technologies, Inc. (NTII) Announces Appointment of William A. Fletcher as Acting CEO 2/4/2009 7:29:12 AM
Neurobiological Technologies, Inc. (NTII) Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine 2/3/2009 8:26:16 AM
Neurobiological Technologies, Inc. (NTII) Ends Stroke Drug Development; Cuts Jobs 1/13/2009 6:32:44 AM
12345678910...
//-->